In 2011, the FDA added two box warnings for this drug in reference to spontaneous tendon ruptures and the fact that moxifloxacin may cause worsening of [[myasthenia gravis]] symptoms, including muscle weakness and life-threatening breathing problems.<ref>http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021085s047,021277s041lbl.pdf</ref>

 

